Boosting, particularly via the intranasal mucosal route, with AdAg85A vaccine is able to significantly enhance the long-term survival of BCG-primed guinea pigs following pulmonary M.tb challenge. Our results thus support further evaluation of this viral-vectored TB vaccine in clinical trials.
No takes yet. Share an insight, caveat, or question.
Xing et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: